Zhao H, Li Y, He L, Pu W, Yu W, Li Y, Wu YT, Xu C, Wei Y, Ding Q, Song BL, Huang H, Zhou B, LIU Qing, YE Peng. In vivo AAV-CRISPR/Cas9-mediated gene editing ameliorates atherosclerosis in familial hypercholesterolemia[J]. Chinese Journal of Hypertension, 2020, 28(3): 299-299. DOI: 10.16439/j.cnki.1673-7245.2020.03.032
|
Citation:
|
Zhao H, Li Y, He L, Pu W, Yu W, Li Y, Wu YT, Xu C, Wei Y, Ding Q, Song BL, Huang H, Zhou B, LIU Qing, YE Peng. In vivo AAV-CRISPR/Cas9-mediated gene editing ameliorates atherosclerosis in familial hypercholesterolemia[J]. Chinese Journal of Hypertension, 2020, 28(3): 299-299. DOI: 10.16439/j.cnki.1673-7245.2020.03.032
|
Zhao H, Li Y, He L, Pu W, Yu W, Li Y, Wu YT, Xu C, Wei Y, Ding Q, Song BL, Huang H, Zhou B, LIU Qing, YE Peng. In vivo AAV-CRISPR/Cas9-mediated gene editing ameliorates atherosclerosis in familial hypercholesterolemia[J]. Chinese Journal of Hypertension, 2020, 28(3): 299-299. DOI: 10.16439/j.cnki.1673-7245.2020.03.032
|
Citation:
|
Zhao H, Li Y, He L, Pu W, Yu W, Li Y, Wu YT, Xu C, Wei Y, Ding Q, Song BL, Huang H, Zhou B, LIU Qing, YE Peng. In vivo AAV-CRISPR/Cas9-mediated gene editing ameliorates atherosclerosis in familial hypercholesterolemia[J]. Chinese Journal of Hypertension, 2020, 28(3): 299-299. DOI: 10.16439/j.cnki.1673-7245.2020.03.032
|
DownLoad: